ABL Bio Shares Rise 1.47% in Early Trading... seesawing in the 75,000-won range
ABL Bio (298380) is showing a rise in the 1% range in early trading on the 26th. Amid a so-called 'seesaw' pattern in which gains and losses have alternated on recent trading days, the stock is heading in an upward direction today. As of 9:29 a.m. on the 26th, ABL Bio is trading at 75,700 won, up 1

ABL Bio (298380) is showing a rise in the 1% range in early trading on the 26th. Amid a so-called 'seesaw' pattern in which gains and losses have alternated on recent trading days, the stock is heading in an upward direction today.
As of 9:29 a.m. on the 26th, ABL Bio is trading at 75,700 won, up 1,100 won (1.47%) from the previous trading day. During the session, it rose as high as the 76,700-won range at one point, posting a gain in the 2% range.
Recently, the stock price has shown a pattern of repeated rises and falls rather than a clear single direction. On the 24th, it closed at 75,600 won, up 0.53% from the previous trading day, and on the 25th, it ended at 75,500 won, down 0.40%. Then, rising again in early trading on the 26th, it continues fluctuating around the 75,000-won level.
Even in the slightly earlier period, volatility was large, but the market trend was difficult to characterize as a one-way upward or downward trend. Gains and losses have alternated by trading day, with the stock price reacting sensitively to short-term supply and demand.
As of 9:29 a.m. today, trading volume was tallied at 103,475 shares. Although buying interest in early trading is pushing the stock up, given recent trends, it is still too early to judge that a new trend has formed based on a single day's movement.
ABL Bio is a biotech company developing new drug candidates, including cancer treatments and therapies for degenerative brain diseases, based on its bispecific antibody platform. Given the nature of biotech stocks, factors such as clinical trial progress, technology transfers, R&D results, and partnerships with global pharmaceutical companies can act as stock price variables.
In the future stock price movement, it is necessary to watch not only news on clinical progress and technology transfers related to key pipelines, but also overall investment sentiment in the biotech sector and supply and demand in the domestic stock market.
[Stock prices can experience greatly expanded volatility depending on domestic and international market trends, industry supply and demand, corporate earnings and disclosures, raw material prices, and policy changes. There is a possibility of sharp short-term swings due to changes in investment sentiment, so future direction should not be determined solely based on intraday fluctuations. Please comprehensively check official disclosures, earnings, business progress, and market supply and demand. This article is not intended to recommend the purchase or sale of specific stocks or to guarantee investment returns. This article was written with AI assistance.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.



